NanoDeNovo: nanobodies designed from the antigen alone
I built a five-stage pipeline that designs nanobodies against the poliovirus type 1 VP3 capsid protein. No immunisation, no display library. It samples scaffolds, predicts their structures, docks them to the antigen, redesigns the CDR loops on whatever survives, and humanises the final candidates. Rosetta relaxation runs last because it costs about a thousand times more per candidate than folding does. The five stages use different models and different failure criteria, so their errors have to be checked separately.
Fig. 8. Kotelnikov, Tatarinova, Zhdanov, 2025. doi:10.3390/ijms26199262. CC BY 4.0.